<DOC>
	<DOC>NCT00669903</DOC>
	<brief_summary>This study is to assess the pharmacodynamics, pharmacokinetics, safety and tolerability of multiple ascending doses of AZD0328 in patients with schizophrenia</brief_summary>
	<brief_title>Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Diagnosis of schizophrenia according to the DSMIV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition) Low level of Extrapyramidal symptoms No clinically significant findings on physical examination Diagnosis of schizoaffective or schizophreniform disorders Any significant psychiatric or neurological disease other than schizophrenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>